Published in Inflammopharmacology on January 01, 2004
Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J Cell Physiol (2008) 1.19
Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology (2009) 1.19
Variability of indication criteria in knee and hip replacement: an observational study. BMC Musculoskelet Disord (2010) 1.03
Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci (2014) 0.96
Changes in Abeta non-nociceptive primary sensory neurons in a rat model of osteoarthritis pain. Mol Pain (2010) 0.91
Osteoarthritis and the impact on quality of life health indicators. Rheumatol Int (2006) 0.87
Delayed onset of changes in soma action potential genesis in nociceptive A-beta DRG neurons in vivo in a rat model of osteoarthritis. Mol Pain (2009) 0.85
Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model. Inflamm Res (2012) 0.84
Gait analysis methods for rodent models of osteoarthritis. Curr Pain Headache Rep (2014) 0.84
Peripheral drive in Aα/β-fiber neurons is altered in a rat model of osteoarthritis: changes in following frequency and recovery from inactivation. J Pain Res (2013) 0.78
Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritis. BMC Musculoskelet Disord (2015) 0.77
Overexpression of MMP13 in human osteoarthritic cartilage is associated with the SMAD-independent TGF-β signalling pathway. Arthritis Res Ther (2015) 0.76
Effects of gangliosides from deer bone extract on the gene expressions of matrix metalloproteinases and collagen type II in interleukin-1β-induced osteoarthritic chondrocytes. Nutr Res Pract (2016) 0.75
TUFT1, a novel candidate gene for metatarsophalangeal osteoarthritis, plays a role in chondrogenesis on a calcium-related pathway. PLoS One (2017) 0.75
No damage of joint cartilage of the lower limbs in an ultra-endurance athlete--an MRI-study. BMC Musculoskelet Disord (2013) 0.75
The musculoskeletal abnormalities of the Similaun Iceman ("ÖTZI"): clues to chronic pain and possible treatments. Inflammopharmacology (2012) 0.75
Sensory nerve action potentials and sensory perception in women with arthritis of the hand. J Neuroeng Rehabil (2012) 0.75
Coumestrol Counteracts Interleukin-1β-Induced Catabolic Effects by Suppressing Inflammation in Primary Rat Chondrocytes. Inflammation (2016) 0.75
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis. J Pain Res (2017) 0.75
Radiological assessment of osteo-arthrosis. Ann Rheum Dis (1957) 42.98
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum (1986) 29.12
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Generalized osteoarthritis and Heberden's nodes. Br Med J (1952) 8.08
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum (1991) 7.94
Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med (2001) 7.41
Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage (1995) 7.18
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol (1988) 6.34
Osteoarthrosis of the knee. A radiographic investigation. Acta Radiol Diagn (Stockh) (1968) 5.38
Epidemiology of hip and knee osteoarthritis. Epidemiol Rev (1988) 4.45
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Osteoarthritis: definitions and criteria. Ann Rheum Dis (1989) 3.50
GENETIC FACTORS IN GENERALIZED OSTEO-ARTHROSIS. Ann Rheum Dis (1963) 3.30
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Radiographic assessment of progression in osteoarthritis. Arthritis Rheum (1987) 3.11
Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis (1993) 2.83
Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis (1993) 2.78
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum (1989) 2.77
Radiographic assessment of the knee joint in osteoarthritis. Ann Rheum Dis (1992) 2.75
Degenerative changes in the intervertebral discs of the lumbar spine and their sequelae. Rheumatol Rehabil (1977) 2.54
Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis (1991) 2.35
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol (2003) 2.33
Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar disc degeneration. J Rheumatol (1993) 2.31
Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum (1995) 2.23
Protocols for precise radio-anatomical positioning of the tibiofemoral and patellofemoral compartments of the knee. Osteoarthritis Cartilage (1995) 2.12
Quantitative aspects of patello-femoral cartilage fibrillation in Liverpool necropsies. Ann Rheum Dis (1974) 2.04
Erosive osteoarthritis of the hands. Arthritis Rheum (1966) 1.98
Compartmental evaluation of osteoarthritis of the knee. A comparative study of available diagnostic modalities. Radiology (1975) 1.98
The natural course of untreated osteoarthritis of the knee. Clin Orthop Relat Res (1977) 1.96
Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol (1992) 1.93
Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views. Arthritis Rheum (2003) 1.93
Osteoarthritis of the knee: comparison of radiography, CT, and MR imaging to assess extent and severity. AJR Am J Roentgenol (1991) 1.91
Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum (1988) 1.91
Determination of fixed charge density in cartilage using nuclear magnetic resonance. J Orthop Res (1992) 1.90
Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence? Osteoarthritis Cartilage (1993) 1.88
In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum (1997) 1.87
Discs degenerate before facets. Spine (Phila Pa 1976) (1990) 1.83
Comparison of visual and radiographic detection of bony changes at the knee joint. BMJ (1990) 1.81
Radiographic assessment of patellofemoral osteoarthritis. Ann Rheum Dis (1993) 1.79
Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee. Arthritis Rheum (1991) 1.79
Primary osteoarthrosis of the knee or hip. Prevalence of Heberden nodes in relation to age and sex. JAMA (1975) 1.67
The relationship between osteophytes in the knee joint, osteoarthritis and aging. Acta Orthop Scand (1973) 1.66
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol (1995) 1.61
Osteoarthritis beginning with inflammation. Definitions and correlations. JAMA (1975) 1.61
Spine radiographs in patients with low-back pain. An epidemiological study in men. J Bone Joint Surg Am (1984) 1.60
Radiographic progression of hospital referred osteoarthritis of the hip. Ann Rheum Dis (1993) 1.57
Detection of knee hyaline cartilage defects using fat-suppressed three-dimensional spoiled gradient-echo MR imaging: comparison with standard MR imaging and correlation with arthroscopy. AJR Am J Roentgenol (1995) 1.55
Diffusion of small solutes in cartilage as measured by nuclear magnetic resonance (NMR) spectroscopy and imaging. J Orthop Res (1993) 1.52
Patello-femoral joint mechanics and pathology. 2. Chondromalacia patellae. J Bone Joint Surg Br (1976) 1.51
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. II. Synovial fluid studies. Arthritis Rheum (1981) 1.50
Survival of articular cartilage after controlled impact. J Bone Joint Surg Am (1977) 1.47
Development of clinical criteria for osteoarthritis. J Rheumatol (1987) 1.46
Joint space width measures cartilage thickness in osteoarthritis of the knee: high resolution plain film and double contrast macroradiographic investigation. Ann Rheum Dis (1995) 1.46
Arthroscopy of the plicae--synovial folds and their significance. Am J Sports Med (1978) 1.45
The current status of ultrasonography in rheumatology. Rheumatology (Oxford) (1999) 1.44
Venous engorgement and intraosseous hypertension in osteoarthritis of the hip. J Bone Joint Surg Br (1972) 1.44
Comparison of tibial cartilage volume and radiologic grade of the tibiofemoral joint. Arthritis Rheum (2003) 1.44
99mTc HMDP bone scanning in generalised nodal osteoarthritis. II. The four hour bone scan image predicts radiographic change. Ann Rheum Dis (1986) 1.43
Periarticular lesions detected on magnetic resonance imaging: prevalence in knees with and without symptoms. Arthritis Rheum (2003) 1.41
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups. Rheumatology (Oxford) (2001) 1.41
An approach to developing criteria for the clinical diagnosis and classification of osteoarthritis: a status report of the American Rheumatism Association Diagnostic Subcommittee on Osteoarthritis. J Rheumatol (1983) 1.40
Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease. J Immunol (1988) 1.40
Severity of articular cartilage abnormality in patients with osteoarthritis: evaluation with fast spin-echo MR vs arthroscopy. AJR Am J Roentgenol (1994) 1.39
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Precision of joint space width measurement in knee osteoarthritis from digital image analysis of high definition macroradiographs. Osteoarthritis Cartilage (1993) 1.34
Interphalangeal osteoarthritis. JAMA (1961) 1.32
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, ad neutral protease with rotator cuff defects. III. Morphologic and biochemical studies of an excised synovium showing chondromatosis. Arthritis Rheum (1981) 1.31
Quantitative microfocal radiographic assessment of osteoarthritis of the knee from weight bearing tunnel and semiflexed standing views. J Rheumatol (1994) 1.28
Inflammatory osteoarthritis. I. The clinical syndrome. J Chronic Dis (1972) 1.27
Abnormalities of articular cartilage in the knee: analysis of available MR techniques. Radiology (1993) 1.24
Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis (1991) 1.24
Recommended methodology for assessing the progression of osteoarthritis of the hip and knee joints. Osteoarthritis Cartilage (1995) 1.21
Milwaukee Shoulder syndrome: eleven additional cases with involvement of the knee in seven (basic calcium phosphate crystal deposition disease). Semin Arthritis Rheum (1984) 1.21
The course of osteoarthritis and factors that affect it. Rheum Dis Clin North Am (1993) 1.20
Radiographic criteria for epidemiologic studies of osteoarthritis. J Rheumatol Suppl (1995) 1.20
Scintigraphic assessment of osteoarthritis of the knee joint. Ann Rheum Dis (1992) 1.19
Is chondromalacia patellae a separate clinical entity? J Bone Joint Surg Br (1978) 1.18
Collagen fibril structure of normal, aging, and osteoarthritic cartilage. J Pathol (1992) 1.16
Quantitative radiography of osteoarthritis. Ann Rheum Dis (1994) 1.15
Weight-bearing radiography in osteoarthritis of the knee. Radiology (1970) 1.14
The experience of pain and emergent osteoarthritis of the knee. Osteoarthritis Cartilage (2001) 1.11
Osteoarthritis: a review of the cell biology involved and evidence for reversibility. Management rationally related to known genesis and pathophysiology. Semin Arthritis Rheum (1984) 1.11
Detection of radiographic joint space narrowing in subjects with knee osteoarthritis: longitudinal comparison of the metatarsophalangeal and semiflexed anteroposterior views. Arthritis Rheum (2003) 1.08
Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. Osteoarthritis Cartilage (1994) 1.07
Experimental assessment by high frequency ultrasound of articular cartilage thickness and osteoarthritic changes. J Rheumatol (1995) 1.06
Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum (1994) 1.06
Meniscal cysts: detection with high-resolution sonography. AJR Am J Roentgenol (1998) 1.05
Peroneal-nerve injury from an enlarged fabella. A case report. J Bone Joint Surg Am (1973) 1.04
COX-2 as a multifunctional neuronal modulator. Nat Med (2001) 1.01
Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis. Rheum Dis Clin North Am (1999) 0.98
Milwaukee shoulder syndrome. Fifteen additional cases and a description of contributing factors. Arch Intern Med (1990) 0.98
Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section. Ann Rheum Dis (1996) 0.98
Quantification of the volume of articular cartilage in the metacarpophalangeal joints of the hand: accuracy and precision of three-dimensional MR imaging. AJR Am J Roentgenol (1995) 0.98
Arthroscopic evaluation of knee articular cartilage: a comparison with plain radiographs and magnetic resonance imaging. J Rheumatol (1994) 0.97
Sonographic evaluation of femoral condylar cartilage in osteoarthritis and rheumatoid arthritis. Scand J Rheumatol (1992) 0.97
The subacromial space in normal shoulder radiographs. Acta Orthop Scand (1984) 0.97
Emerging applications of magnetic resonance imaging in the evaluation of articular cartilage. Radiol Clin North Am (1996) 0.95
Nocturnal pain correlates with effusions in diseased hips. J Rheumatol (1992) 0.95
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol (1986) 1.70
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60
Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. Br J Clin Pharmacol (1978) 1.59
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol (1992) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Depression in rheumatoid arthritis. J R Coll Gen Pract (1977) 1.52
Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol (1979) 1.52
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann Rheum Dis (1968) 1.47
Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol (1966) 1.43
Prior score availability: observations using the WOMAC osteoarthritis index. Br J Rheumatol (1991) 1.43
Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol (1973) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A (1997) 1.42
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol (1991) 1.40
Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol (1994) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Are gallstones less prevalent in rheumatoid arthritis? Clin Rheumatol (1991) 1.39
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol (1983) 1.35
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol (1976) 1.31
Auranofin. Br J Rheumatol (1997) 1.30
Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent. Ann Rheum Dis (1972) 1.28
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.28
Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med (1967) 1.25
Generalised and localised bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.21
Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci U S A (1995) 1.21
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis. Health Bull (Edinb) (1975) 1.19
Distribution of certain autoantibodies in monozygotic and dizygotic twins. Ann Rheum Dis (1966) 1.17
Outcome measurement in osteoarthritis clinical trials: the case for standardisation. Clin Rheumatol (1984) 1.17
Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1987) 1.16
Poor quality of posts in clinical rheumatology: a cause of failure to advance the specialty. Br Med J (1976) 1.15
Radioisotope study of small joint inflammation in rheumatoid arthritis. Ann Rheum Dis (1971) 1.15
Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis. J Rheumatol (1984) 1.15
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol (1972) 1.13
Antirheumatic drugs: clinical pharmacology and therapeutic use. Drugs (1980) 1.12
Pulmonary involvement in systemic lupus erythematosus. Ann Rheum Dis (1978) 1.11
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique. Clin Sci (1971) 1.10
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.10
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index. J Rheumatol (1994) 1.10
Serum uric acid in England and Scotland. Ann Rheum Dis (1977) 1.10
Pulmonary infection and rheumatoid arthritis. Br J Dis Chest (1978) 1.10
A comparative study of some commercially available tests for rheumatoid factor. J Clin Pathol (1974) 1.09
Relative roles of genetic and environmental factors in the control of serum uric acid levels in normouricaemic subjects. Ann Rheum Dis (1967) 1.08
NSAID and osteoarthritis--help or hindrance? J Rheumatol (1982) 1.07
Plasma immunoglobulin concentrations in twins. Clin Exp Immunol (1968) 1.07
Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol (1976) 1.06
Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis (1978) 1.05
Bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.05
Observations on drug prescribing in rheumatoid arthritis. Br Med J (1974) 1.05
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol (1991) 1.04
Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis (2002) 1.04
Indomethacin--aspirin interaction: a clinical appraisal. Br Med J (1975) 1.04
Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy. Ann Rheum Dis (1968) 1.03
The detection of spinal pseudarthrosis in ankylosing spondylitis. Br J Radiol (1981) 1.01
Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis (1991) 1.00
Bone-resorbing activity in the sera of patients with rheumatoid arthritis. Clin Sci Mol Med (1976) 1.00
Personal points of view--the need for expansion of medical social work facilities and personnel in rheumatology. Health Bull (Edinb) (1974) 1.00
Clinical evaluation of two strategies for improving patient recall of prior drug therapy. Br J Clin Pharmacol (1984) 1.00
Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann Rheum Dis (1970) 0.99
Inheritance of ankylosing spondylitis and HL-A antigen W27. Lancet (1974) 0.98
Methods of assessment used in ankylosing spondylitis clinical trials: a review. Br J Rheumatol (1991) 0.98
The economics of arthritis. Bull Rheum Dis (1973) 0.98
Interactions of anti-rheumatic drugs. Agents Actions Suppl (1977) 0.97
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol (1991) 0.97
Some clinical observations on the diurnal rhythm of plasma cortisol (11-OHCS) in patients with rheumatoid arthritis treated with oral corticosteroid drugs. Curr Med Res Opin (1974) 0.97
Antinuclear factors in synovial fluids. Lancet (1967) 0.97
The management of rheumatoid arthritis. Anglo Ger Med Rev (1968) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
Reiter's syndrome re-evaluated. Scott Med J (1979) 0.96
Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Ann Rheum Dis (1973) 0.96
Nocturnal pain correlates with effusions in diseased hips. J Rheumatol (1992) 0.95